Full Text View
Tabular View
No Study Results Posted
Related Studies
A Retrospective Review of Infections Usually Observed in Transplant Recipients
This study is currently recruiting participants.
Verified by University of Pittsburgh, December 2008
First Received: February 27, 2006   Last Updated: December 16, 2008   History of Changes
Sponsors and Collaborators: University of Pittsburgh
Physicians own funding
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00298077
  Purpose

The study will identify patients with infections commonly observed in transplant recipients, describe the epidemiology of their infection, study the risk factors associated with various infections and examine strategies of early diagnosis and prevention of infection


Condition
Infection
Organ Transplant Recipients

U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: A Retrospective Review of Infections Usually Observed in Transplant Recipients

Further study details as provided by University of Pittsburgh:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

No genetic testing will be performed on any of the samples being obtained. The biologic samples will be under the control of the principal investigator of this research project. To protect confidentiality, all personal identifiers (i.e., name, social security number, and birth date) will be removed (de-identified) and replaced with a specific code number. The information linking these code numbers to the corresponding subjects' identities will be kept in a separate, secure location. The investigators on this study will keep the samples indefinitely. If a subject withdraws and provides the request in writing, samples collected and not already processed will be destroyed. All samples will be kept in the investigator's laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.


Estimated Enrollment: 500
Study Start Date: August 2006
Estimated Study Completion Date: December 2016
Detailed Description:

The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, previous medical surgical conditions, microbiology and virology culture results, laboratory and radiographical data, antimicrobial usage of onset of infection, microbiological data and resistance patterns, choice of antibiotics once organism identified, suspected source of infection, bacteriological outcomes, laboratory results, demographic information, pathology and histology results, summaries of admissions, discharges, operations, death, medications, clinical outcome gender, height, weight, ethnicity, date of transplant, type of transplant, primary diagnosis, and past medical history. Also required are medical summaries of admissions, discharges, operations, and deaths

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

transplant recipients with infections

Criteria

Inclusion Criteria:

  • Patients who receive medical care at UPMC
  • Patients who developed infections usually observed in transplant recipients

Exclusion:

  • Patients who do not receive medical care in UPMC Oakland campus
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00298077

Contacts
Contact: Eun Kwak, MD 412-648-6401 kwakej@upmc.edu
Contact: Diana Lynn Pakstis, RN, BSN 412-648-6553 pakstisdl@dom.pitt.edu

Locations
United States, Pennsylvania
University of Pittsburgh Medical Center Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Eun Kwak, MD     412-648-6401     kwakej@upmc.edu    
Contact: Diana Lynn Pakstis, RN, BSN     412-648-6553     pakstisdl@dom.pitt.edu    
Principal Investigator: Eun Kwak, MD            
Sponsors and Collaborators
University of Pittsburgh
Physicians own funding
Investigators
Principal Investigator: Eun Kwak, MD University of Pittsburgh
  More Information

No publications provided

Responsible Party: UPMC ( E. J. Kwak, MD )
Study ID Numbers: IRB# 0602053
Study First Received: February 27, 2006
Last Updated: December 16, 2008
ClinicalTrials.gov Identifier: NCT00298077     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
Infection
transplant recipients

Additional relevant MeSH terms:
Communicable Diseases
Infection

ClinicalTrials.gov processed this record on May 06, 2009